Atlas Trials

Tyra Biosciences, Inc

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Tyra Biosciences, Inc

RecordFirmDate
Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma (NCT07265947)Tyra Biosciences, Inc2025-12-22
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer (NCT06995677)Tyra Biosciences, Inc2025-06-27
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations (NCT06915753)Tyra Biosciences, Inc2025-04-24
A Study of TYRA-300 in Children With Achondroplasia: BEACH301 (NCT06842355)Tyra Biosciences, Inc2025-03-04
Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations (NCT06160752)Tyra Biosciences, Inc2023-11-22
A Relative Bioavailability and Food Effect Study of TYRA-300-B01 Capsule and Tablet Formulations in Healthy Adult Participants (NCT06006702)Tyra Biosciences, Inc2023-10-16
Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations (NCT05544552)Tyra Biosciences, Inc2022-11-22

Track Tyra Biosciences, Inc automatically

Every clearance here is in the API, with alerts when new ones post.